NasdaqGS:AMGNBiotechs
Amgen (AMGN): Earnings Surge 111% Challenges Bearish Views on Profitability Turnaround
Amgen (AMGN) posted standout earnings growth of 111.5% over the past year, sharply reversing the company’s five-year average earnings decline of 6.4% per year. Net profit margins showed solid improvement, climbing to 19% from 10.1% in the prior year. Future earnings are expected to rise 12.5% per year compared to a slightly faster 15.8% forecast for the broader US market. With profitability and dividends looking attractive, the latest earnings season numbers give investors plenty to...